EICHORPublic-registry site landscape for NCT07697456, “Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis”, a Crohn's Disease study sponsored by AbbVie. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07697456 (registry record) |
| Study title | Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis |
| Official title | A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis |
| Sponsor | AbbVie |
| Condition(s) | Crohn's Disease; Ulcerative Colitis |
| Phase | PHASE2 |
| Listed sites | 30 |
| Site countries | United States, Australia, Belgium, Germany, Japan, Slovenia, South Africa, Spain, Switzerland |
Patient-friendly overview of this study: eichor.com/study/NCT07697456.
Eichor generates a preliminary site-risk snapshot for NCT07697456 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Crohn's Disease trials
More from AbbVie
← Eichor home · All tracked trials · Crohn's Disease studies · Weekly briefs
